James E Flynn
James E Flynn's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link…
Insider buying and selling since 2014
James E Flynn bought shares on the open market in 7 different years since 2014 across 11 companies. Sales in 4 of the 13 years since 2014.
James E Flynn reported 30 open-market purchases and 23 sales since 2014; purchases in 7 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 4×4 trades | — |
| 2025 | 3×3 trades | 2×2 trades |
| 2024 | — | 8×8 trades |
| 2021 | 1×1 trade | — |
| 2019 | 1×1 trade | 4×4 trades |
| 2018 | 3×3 trades | — |
| 2017 | — | 9×9 trades |
| 2015 | 8×8 trades | — |
| 2014 | 10×10 trades | — |
Insider at 11 companies
- Larimar Therapeutics LRMR2025–2026 · 7 purchases, 0 sales
- Ars Pharmaceuticals SPRY2024–2025 · 0 purchases, 10 sales
- Werewolf Therapeutics HOWL2021 · 1 purchase, 0 sales
- Aclaris Therapeutics ACRS2019 · 0 purchases, 4 sales
- Mirum Pharmaceuticals MIRM2019 · 1 purchase, 0 sales
- Arvinas ARVN2018 · 2 purchases, 0 sales
- AdaptHealth Corp. AHCO2018 · 1 purchase, 0 sales
- Ehealth EHTH2014–2017 · 12 purchases, 9 sales
- Vanda Pharmaceuticals VNDA2015 · 3 purchases, 0 sales
- Cytomx Therapeutics CTMX2015 · 2 purchases, 0 sales
- Atyr Pharma ATYR2015 · 1 purchase, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about James E Flynn's trades
Has James E Flynn bought shares on the open market?
James E Flynn bought shares on the open market in 7 different years since 2014 across 11 companies. Sales in 4 of the 13 years since 2014.
When did James E Flynn last buy or sell shares?
In SEC filings since 2014: the latest open-market purchase is from 2026; the latest open-market sale is from 2025.
Which companies has James E Flynn traded as an insider?
11 companies: Larimar Therapeutics (LRMR, 2025–2026), Ars Pharmaceuticals (SPRY, 2024–2025), Werewolf Therapeutics (HOWL, 2021), Aclaris Therapeutics (ACRS, 2019), Mirum Pharmaceuticals (MIRM, 2019) and others.